Lung Non-Squamous Non-Small Cell Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

408 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 93
Recruiting: 47
Ph III recruiting: 15
Growth YoY: —
Industry share: 39%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (55)

clinicaltrialsPublishedShowing 1–24 of 24 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07489066	Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC	recruiting	Phase 2	120	PfizerINDUSTRY	8	Sep 25, 2026	clinicaltrials
NCT04105270	RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial	recruiting	Phase 2	82	Masonic Cancer Center, University of MinnesotaOTHER	1	Sep 17, 2026	clinicaltrials